Center for Human Genetics, Cliniques Universitaires Saint-Luc, de Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Genes Chromosomes Cancer. 2013 Jan;52(1):81-92. doi: 10.1002/gcc.22008. Epub 2012 Sep 25.
We previously showed that complex karyotypes (CK) and chromosome 13q abnormalities have an adverse prognostic impact in childhood Burkitt lymphomas/leukemias (BL) and diffuse large B-cell lymphomas (DLBCL). The aim of our study was to identify recurrent alterations associated with MYC rearrangements in aggressive B-cell lymphomas with CK. Multicolor fluorescence in situ hybridization (M-FISH) was performed in 84 patient samples (59 adults and 25 children), including 37 BL (13 lymphomas and 24 acute leukemias), 12 DLBCL, 28 B-cell lymphomas with intermediate features (DLBCL/BL), 4 B-cell precursor acute lymphoblastic leukemias (BCP-ALL), and 3 unclassifiable B-cell lymphomas. New (cytogenetically undetected) abnormalities were identified in 80% of patients. We also refined one-third of the chromosomal aberrations detected by karyotyping. M-FISH proved to be more useful in identifying chromosomal partners involved in unbalanced translocations and in revealing greater complexity of 13q rearrangements. Most of the newly identified or refined recurrent alterations involved 1q, 13q and 3q (gains/losses), 7q and 18q (gains), or 6q (losses), suggesting that these secondary aberrations may play a role in lymphomagenesis. Several patterns of genomic aberrations were identified: 1q gains in BL, trisomies 7 in DLBCL, and 18q-translocations in adult non-BL. BCP-ALL usually displayed an 18q21 rearrangement. BL karyotypes were less complex and aneuploid than those of other MYC-rearranged lymphomas. BCP-ALL and DLBCL/BL were associated with a higher rate of early death than BL and DLBCL. These findings support the categorization of DLBCL/BL as a distinct entity and suggest that BL with CK are indeed different from other aggressive MYC-rearranged lymphomas, which usually show greater genetic complexity. © 2012 Wiley Periodicals, Inc.
我们之前的研究表明,在儿童伯基特淋巴瘤/白血病(BL)和弥漫性大 B 细胞淋巴瘤(DLBCL)中,复杂核型(CK)和 13q 染色体异常对预后有不良影响。本研究的目的是鉴定与 CK 相关的伴有 MYC 重排的侵袭性 B 细胞淋巴瘤中常见的改变。对 84 例患者样本(59 例成人和 25 例儿童)进行了多色荧光原位杂交(M-FISH)检测,包括 37 例 BL(13 例淋巴瘤和 24 例急性白血病)、12 例 DLBCL、28 例中间特征的 B 细胞淋巴瘤(DLBCL/BL)、4 例 B 细胞前体急性淋巴细胞白血病(BCP-ALL)和 3 例未分类的 B 细胞淋巴瘤。在 80%的患者中发现了新的(细胞遗传学上未检测到的)异常。我们还修正了核型分析检测到的三分之一的染色体异常。M-FISH 被证明在鉴定涉及不平衡易位的染色体伙伴和揭示更复杂的 13q 重排方面更有用。新发现或修正的常染色体异常主要涉及 1q、13q 和 3q(增益/缺失)、7q 和 18q(增益)或 6q(缺失),这表明这些次级异常可能在淋巴瘤发生中发挥作用。鉴定出几种基因组异常模式:BL 中 1q 增益、DLBCL 中 7 三体和成人非 BL 中的 18q 易位。BCP-ALL 通常显示 18q21 重排。BL 核型比其他 MYC 重排的淋巴瘤简单且非整倍体。BCP-ALL 和 DLBCL/BL 的早期死亡率高于 BL 和 DLBCL。这些发现支持将 DLBCL/BL 归类为一种独特的实体,并表明 CK 相关的 BL 确实与其他侵袭性 MYC 重排的淋巴瘤不同,后者通常显示出更大的遗传复杂性。© 2012 年 Wiley 期刊,Inc.